Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Himsnab Bulgaria AD's revenue for the
three
months ended in Mar. 2026 was лв9.38 Mil.
Its revenue for the trailing twelve months (TTM) ended in Mar. 2026 was лв24.44 Mil.
Himsnab Bulgaria AD's Revenue per Share for the
three
months ended in Mar. 2026 was лв3.76.
Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was лв9.80.
Warning Sign:
Himsnab Bulgaria AD revenue per share is in decline over the past 12 months.
During the past 12 years, Himsnab Bulgaria AD's highest 3-Year average Revenue per Share Growth Rate was 92.60% per year. The lowest was 34.40% per year. And the median was 50.10% per year.
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Himsnab Bulgaria AD Revenue Related Terms
Himsnab Bulgaria AD Revenue Historical Data
* Premium members only.
The historical data trend for Himsnab Bulgaria AD's Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Real Estate Services subindustry, Himsnab Bulgaria AD's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Himsnab Bulgaria AD Revenue vs Real Estate Industry
For the Real Estate industry and Real Estate sector, Himsnab Bulgaria AD's Revenue distribution charts can be found below:
* The bar in red indicates where Himsnab Bulgaria AD's Revenue falls into.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was лв24.44 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Himsnab Bulgaria AD (LTS:0N22) has a Revenue of лв24.44 Mil as of Mar. 2026. Revenue is the total amount a company generates as sales through its operations. View historical data on Himsnab Bulgaria AD and its competitors.
Is Himsnab Bulgaria AD's Revenue too high?
Himsnab Bulgaria AD's current Revenue is лв24.44 Mil. Overall, Himsnab Bulgaria AD has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Himsnab Bulgaria AD's Revenue compare to CBRE and BEKE?
Himsnab Bulgaria AD's Revenue of лв24.44 Mil can be compared against companies in the Real Estate industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Real Estate company?
A good Revenue depends on the Real Estate industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Himsnab Bulgaria AD and its competitors. Himsnab Bulgaria AD's current Revenue is лв24.44 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Himsnab Bulgaria AD stock overvalued right now?
Himsnab Bulgaria AD (LTS:0N22) has a current Revenue of лв24.44 Mil. The current Revenue is лв24.44 Mil. Himsnab Bulgaria AD's overall GF Score™ is 25/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Himsnab Bulgaria AD (LTS:0N22), the current Revenue is лв24.44 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0N22 has been successfully added to your 
